Atlas Trials

Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis

Clinical trial NCT01792713 · COMPLETED

Trial details

NCT number
NCT01792713
Sponsor
Spirig Pharma Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Skin Alterations Associated With Atopic Dermatitis
Start date
2013-02-01
Primary completion
2013-09-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.